Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis
- First Posted Date
- 2024-04-09
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- John Sledge
- Target Recruit Count
- 23
- Registration Number
- NCT06354023
- Locations
- 🇺🇸
BioShift Life Sciences, Santa Monica, California, United States
News
No news found